Terminal illness FCA review – a welcome call for improved customer outcomes L&H Documents December 14, 2023
GLP-1 receptor agonists: An exciting new wave of treatments for obesity L&H Documents December 14, 2023
Protection Claims – what are the trends telling us about how the industry is performing in the UK? L&H Documents December 13, 2023
HIV - A new era of hope to end the epidemic and revised underwriting guidelines L&H Documents September 27, 2023
